R. Persson

First name
R.
Last name
Persson
Hagberg, K. W., Vasilakis-Scaramozza, C., Persson, R., Neasham, D., Kafatos, G., & Jick, S. (2023). Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1). Clin Epidemiol, 15, 1183-1192. http://doi.org/10.2147/clep.s434795
View
Hagberg, K. W., Vasilakis-Scaramozza, C., Persson, R., Neasham, D., Kafatos, G., & Jick, S. (2023). Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2). Clin Epidemiol, 15, 1193-1206. http://doi.org/10.2147/clep.s434829
View
Jick, S., Vasilakis-Scaramozza, C., Persson, R., Neasham, D., Kafatos, G., & Hagberg, K. W. (2023). Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments. Clin Epidemiol, 15, 1219-1222. http://doi.org/10.2147/clep.s434832
View
Vasilakis-Scaramozza, C., Hagberg, K. W., Persson, R., Kafatos, G., Maskell, J., Neasham, D., & Jick, S. (2023). Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3). Clin Epidemiol, 15, 1207-1218. http://doi.org/10.2147/clep.s434831
View
Vasilakis-Scaramozza, C., Hagberg, K. W., Persson, R., Yelland, E., Williams, T., Myles, P., & Jick, S. S. (2022). Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5551
View
Persson, R., Cordey, M., Paris, M., & Jick, S. (2022). Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink. Drug Saf, 1-9. http://doi.org/10.1007/s40264-022-01235-7
View
Persson, R., Hagberg, K. W., Vasilakis-Scaramozza, C., Yelland, E., Williams, T., Myles, P., & Jick, S. S. (2022). Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments. Clin Epidemiol, 14, 641-652. http://doi.org/10.2147/clep.s360843
View
Hagberg, K. W., Divan, H. A., Persson, R., Nickel, J. C., & Jick, S. S. (2016). Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. Bmj. http://doi.org/10.1136/bmj.i4823
View
Persson, R., Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., et al. (2019). Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries. J Neurol. http://doi.org/10.1007/s00415-019-09238-8
View
Persson, R., & Jick, S. (2019). Clinical implications of the association between fluoroquinolones and tendon rupture: the magnitude of the effect with and without corticosteroids. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13879
View